Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-15.73	-21.15	-44.88	-42.04	-57.2	-33.24
Depreciation & Amortization	4.65	4.25	2.9	1.99	1.81	1.4
Share-Based Compensation	90.57	82.47	51.97	26.18	12.82	6.2
Other Operating Activities	-44.62	-40.91	1.58	-6.24	-10.47	-7.2
Operating Cash Flow	34.86	24.65	11.57	-20.12	-53.05	-32.85
Operating Cash Flow Growth	51.73%	113.10%	-	-	-	-
Capital Expenditures	-31.57	-23.63	-9.1	-4.67	-2.46	-2.74
Change in Investments	-279.03	-271.19	-10.5	33.81	89.08	-40.82
Investing Cash Flow	-310.6	-294.82	-19.6	29.14	86.63	-43.56
Share Issuance / Repurchase	27.35	31.11	259.62	14.95	134.07	2.5
Debt Issued / Paid	0	0	-24.5	0	0	0
Other Financing Activities	-18.26	-17.16	-0.04	-	-	-0.53
Financing Cash Flow	9.09	13.95	235.08	14.95	134.07	1.96
Exchange Rate Effect	-0.06	0.16	0.08	-0.02	0.01	0.01
Net Cash Flow	-266.72	-256.06	227.13	23.95	167.66	-74.43
Free Cash Flow	3.29	1.02	2.47	-24.79	-55.5	-35.59
Free Cash Flow Growth	-71.03%	-58.59%	-	-	-	-
Free Cash Flow Margin	0.50%	0.16%	0.61%	-10.62%	-48.10%	-43.37%
Free Cash Flow Per Share	0.11	0.04	0.09	-0.91	-2.13	-1.50

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).